Aprea Therapeutics (APRE)
(Delayed Data from NSDQ)
$5.17 USD
-0.20 (-3.72%)
Updated Apr 24, 2024 03:15 PM ET
After-Market: $5.21 +0.04 (0.77%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/20/2024
Time: -- |
3/2024 | $-0.78 | 0.00% |
Earnings Summary
For their last quarter, Aprea Therapeutics (APRE) reported earnings of -$0.92 per share, missing the Zacks Consensus Estimate of -$0.56 per share. This reflects a negative earnings surprise of 64.29%. Look out for APRE's next earnings release expected on May 20, 2024. For the next earning release, we expect the company to report earnings of -$0.78 per share, reflecting a year-over-year increase of 41.79%.
Earnings History
Price & Consensus
Zacks News for APRE
FDA Accepts Merck (MRK) sNDA for Welireg in Renal Cell Carcinoma
APRE: What are Zacks experts saying now?
Zacks Private Portfolio Services